Articles related to METASTASIS

IL-1B significantly influences breast cancer bone metastasis by promoting EMT, enhancing osteoclast activity, and creating a conducive metastatic niche. Targeting IL-1B in combination with standard therapies shows promising potential to reduce metastatic outgrowth.

Recent findings indicate that pre-WBRT administration of bevacizumab, etoposide, and cisplatin (BEEP) may significantly improve brain-specific progression-free survival in breast cancer patients with brain metastases.

Recent research reveals aspirin’s significant impact on reducing cancer mortality and preventing metastatic spread, offering a promising addition to cancer therapy protocols.

Explore how metixene, a repositioned antiparkinsonian drug, emerges as a promising agent in treating metastatic breast cancer and brain metastases, redefining therapeutic approaches in oncology.

Discover how mechanoresilient cancer cells evade the body’s natural defenses and what this means for the future of targeted cancer therapies.

This case study highlights the critical role of early diagnosis in managing alopecia neoplastica, a rare but significant indicator of metastatic spread in cancer patients. Learn more about the diagnostic challenges and implications for treatment.